Banerjee 2013 Autism
Banerjee 2013 Autism
Abstract
The biological mechanisms of autism spectrum disorders (ASDs) are largely unknown in spite of extensive
research. ASD is characterized by altered function of multiple brain areas including the temporal cortex and by
an increased synaptic excitation :inhibition ratio. While numerous studies searched for evidence of increased
excitation in ASD, fewer have investigated the possibility of reduced inhibition. We characterized the cortical
c-amino butyric acid (GABA)ergic system in the rat temporal cortex of an ASD model [offspring of mothers
prenatally injected with valproic acid (VPA)], by monitoring inhibitory post-synaptic currents (IPSCs) with
patch-clamp. We found that numerous features of inhibition were severely altered in VPA animals compared to
controls. Among them were the frequency of miniature IPSCs, the rise time and decay time of electrically-evoked
IPSCs, the slope and saturation of their input/output curves, as well as their modulation by adrenergic and
muscarinic agonists and by the synaptic GABAA receptor allosteric modulator zolpidem (but not by the extra-
synaptic modulator gaboxadol). Our data suggest that both pre- and post-synaptic, but not extra-synaptic,
inhibitory transmission is impaired in the offspring of VPA-injected mothers. We speculate that impairment
in the GABAergic system critically contributes to an increase in the ratio between synaptic excitation and inhi-
bition, which in genetically predisposed individuals may alter cortical circuits responsible for emotional, com-
munication and social impairments at the core of ASD.
Received 10 August 2012 ; Reviewed 27 August 2012 ; Revised 6 September 2012 ; Accepted 7 September 2012 ;
First published online 11 December 2012
Key words : ASD, interneurons, patch-clamp, temporal cortex, VPA.
We used the same animal model to test the possibility of (10 mM) and kynurenate (2 mM) for blocking a-amino-
impaired efficacy of c-amino butyric acid (GABA)ergic 3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
synaptic function, which is under increasing scrutiny as a and N-methyl-D-aspartate receptor-mediated currents,
potentially critical factor in the development of ASDs respectively.
(Hussman, 2001 ; Pizzarelli and Cherubini, 2011).
We found that pre-synaptic and post-synaptic, but not Drugs
extra-synaptic, GABAergic function and its modulation
are severely compromised in VPA animals compared to All drugs were purchased from Sigma (USA), Tocris
controls. These data raise the possibility that a derange- (USA) and Alomone Laboratories (Israel). Stock solutions
ment in the developing GABAergic system increases the of all drugs were prepared in water except for oxo-
ratio between synaptic excitation and inhibition, bringing tremorine, of which stock solution (10 mM) was prepared
about a critical contribution to core symptoms of ASD. in ethanol. For non-aqueous solutions, the final concen-
tration of the solvent was added to the recording control
solution. After recording an initial baseline for 7–10 min,
Method drugs were bath-applied for 5 min or longer, until
Animals reaching a stable condition.
Drug effects were assessed by measuring and comparing was calculated between the first two non-null responses
the different parameters (IPSC mean amplitude, PPR and of each curve. The saturation current was the maximum
others) between controls vs. VPA animals, with paired eIPSC amplitude observed and typically did not signifi-
Student’s t test. Data were reported as different only if cantly change in the rightmost part of the I/O curve.
p<0.05 % (* p<0.05, ** p<0.02), unless indicated other- While the response threshold (Fig. 2b) was similar in
wise. Quantal analysis was performed to identify the control (30¡5 mA, n=12) and VPA animals (20¡10 mA,
locus of defect in VPA animals affecting post-synaptic n=10, n.s., unpaired Student’s t test), eIPSC slope and
current amplitudes. We used a coefficient of variation saturation levels were significantly lower in VPA animals
(CV) analysis similar to the one reported by Faber and compared to controls (slope 1.4¡0.4 pA/mA in VPA,
Korn (1991) and by Zucker and Regehr (2002) to deter- 0.35¡0.15 in control, p<0.02 ; saturation 165¡42 pA in
mine the synaptic locus. VPA, vs. 841¡148 pA in control, p<0.02 ; Fig. 2c, d) in-
dicating that GABAergic transmission in VPA animals
did not even reach 20 % of control.
Results
Analysis of paired pulse stimulation at an interpulse
The temporal lobes of mammals including rats, humans delay of 50 ms (example in Fig. 2 e, f) showed that PPR
and other species host multiple auditory and communi- and CV did not significantly differ between VPA and
cation-related areas and are critically impaired in ASD control animals (representative traces in Fig. 2 e, f for
(Hazlett et al. 2011 ; Suzuki et al. 2011). For this reason we control and VPA respectively ; PPR 1.02¡0.04 in control
compared the temporal cortex in VPA vs. control animals vs. 0.90¡0.12 in VPA, p>0.05 ; 1/CV2 175¡71 in control
using electrophysiological recording. vs. 77¡36 in VPA, n.s.). Consistent with the finding of the
mIPSC, the decay time was slower in VPA animals com-
Miniature IPSC impairment in VPA animals pared with controls (t=64.3¡6.3 ms in control vs.
110.3¡15.4 ms in VPA animals, p<0.05). These results
We compared the mIPSCs, recorded in the presence of
indicate the presence of a deficit in the GABAergic
the Na+ channel blocker tetrodotoxin (0.5 mM) between
transmission of VPA animals.
control and VPA animals. Representative traces are
shown in Fig. 1 a. The frequency of the mIPSC was sig-
nificantly reduced in VPA animals compared to controls Synaptic but not extra-synaptic GABAAR-mediated
(1.39¡0.21 Hz in VPA vs. 3.05¡0.64 Hz in controls, currents are selectively impaired in VPA animals
n=10, p<0.05, Student’s t test ; Fig. 1b), while the mean
GABAA receptors (GABAARs) in the central nervous
mIPSC amplitude did not differ significantly (Fig. 1c).
system are localized both synaptically as well as extra-
Analysis of mIPSC kinetics revealed that both rise and
synaptically (Drasbek and Jensen, 2006). In order to deter-
decay time were significantly slower in the VPA animals
mine the contribution of synaptic GABAARs we recorded
(rise time : 0.81¡0.05 ms in VPA vs. 0.63¡0.03 ms in
layer II/III eIPSC response to zolpidem, an allosteric
controls, n=8 ; p<0.05, unpaired Student’s t test ; decay
modulator of GABAARs that preferentially binds to a1
time : 33.0¡5.7 ms in VPA vs. 18.1¡3.3 ms in controls,
and a2/3 subunits of GABAARs located mostly within
p<0.02, unpaired Student’s t test, n=10 ; Fig. 1 f). While
post-synaptic densities (Jacob et al. 2008). While we
changes in mIPSC frequency suggest pre-synaptic differ-
found that eIPSC in both VPA and control animals were
ences, different kinetics would indicate post-synaptic al-
enhanced after application of zolpidem (0.5 mM), the ex-
terations in GABAergic transmission.
tent of zolpidem-induced increase in eIPSC amplitude
was significantly smaller in VPA animals (+29¡4 %,
Input/output response of electrically-evoked IPSCs
n=9), compared to control animals (+55¡1.7 %, p>0.05,
While the source of mIPSCs is not exactly known, elec- n=12, unpaired Student’s t test). Figure 3 a, b shows rep-
trically-evoked synaptic currents likely originate from resentative examples of the eIPSC amplitude time-course
stimulation of axons surrounding the stimulation elec- following zolpidem application in control and VPA ani-
trode. We obtained eIPSCs by stimulating cortical layer mals respectively. The mean increment is shown in
II/III at about 200 mM from the recorded cell. We com- Fig. 3c.
pared GABAergic transmission between control and VPA Extra-synaptic currents are an important determinant
animals and determined the synaptic output as a function of neuronal excitability. 4,5,6,7-Tetrahydroisoxazolo(5,4-
of increasing stimulation intensity (see Method). Each c)pyridin-3-ol (THIP, gaboxadol) binds specifically to d
point in the input/output (I/O) curves corresponds to subunits present extra-synaptically (Drasbek and Jensen,
averaged responses over 4–10 extracellular electrical re- 2006). We estimated the response of extra-synaptic
sponses delivered at the same intensity (example of I/O GABAAR by determining the change in picrotoxin sensi-
curve in Fig. 2 a). For each recording three parameters tive holding current following bath application of
were extracted : response threshold ; initial slope ; satu- gaboxadol (5 mM). Figure 3d, e display representative
ration current. The threshold was the smallest intensity time-course of the tonic current from layer II/III neurons
eliciting a non-zero synaptic response. The initial slope in control and VPA animals respectively, measured as
(a) (b)
Con
50 pA
VPA 100 ms
20 pA
Con
VPA 50 ms
50 pA
100 ms
(c) (d)
4 25
20
3
Amplitude (pA)
Frequency (Hz)
*
15
2
10
1
5
0 0
Con VPA Con VPA
(e) (f)
1.0 50
0.8 * 40
Decay time (ms)
Rise time (ms)
*
0.6 30
0.4 20
0.2 10
0.0 0
Con VPA Con VPA
Fig. 1. Miniature inhibitory post-synaptic current (mIPSCs) in control and valproic acid (VPA) animals. (a) Representative traces of
mIPSCs from layer II/III pyramidal cells of control and VPA animals in the presence of tetrodotoxin (0.5 mM). (b) Average of 20 aligned
mIPSCs in control or VPA animals (expanded scaling ; control, black ; VPA, grey). (c and d) Average frequency and amplitude,
respectively, of mIPSCs in control and VPA (n=10 each). (e and f) The mIPSC rise time and decay time in VPA and controls. VPA
mIPSC displayed a lower frequency and slower kinetics compared to control animals. * p<0.05.
picrotoxin-sensitive component of the holding current from our laboratory have shown that GABAergic term-
following application of gaboxadol (Drasbek and Jensen, inals are subject to intense pre-synaptic modulation by
2006). The tonic current did not significantly differ be- adrenergic and muscarinic receptors. In fact the acti-
tween control and VPA animals (37¡4.8 % pA, n=10 vs. vation of pre-synaptic adrenoceptors increases eIPSC
30¡7.6 % pA in control, n=9, n.s., Student’s t test ; amplitude (Salgado et al. 2011), while activation of mus-
Fig. 3 f). Altogether, these results suggest a selective im- carinic receptors decreases eIPSC amplitude (Salgado
pairment of GABAARs. et al. 2007). We considered the possibility that GABAergic
terminals in VPA animals responded to adrenergic or
Impaired pre-synaptic modulation of inhibitory
muscarinic agonists differently from controls. As in the
transmission in VPA animals
previous series of experiments, eIPSCs were recorded
A lower frequency in mIPSCs raises the possibility of pre- from cortical layer II/III neurons after stimulation of the
synaptic impairment in VPA animals. Previous studies same layer.
**
Threshold (µA)
Slope (pA/µA)
1.0 30 16
0.8 **
20 10 0.6
0.5 Initial slope
0.4
10 5
Threshold 0.2
0.0 0 0 0.0
0 05 100 150 200 Con VPA Con VPA Con VPA
Stimulation intensity (µA)
1/CV2
80
PPR
0.6 150
60
0.4 100
100 pA
100 pA
40
0.2 50 20
50 ms 50 ms
0.0 0 0
Con VPA Con VPA Con VPA Con VPA
Fig. 2. Basal inhibitory synaptic transmission in control and valproic acid (VPA) animals. (a) Example of input/output (I/O) curve.
Each trace corresponds to the averaged responses over at least four extracellular electrical pulses delivered at the same intensity.
(b–d) I/O curve threshold, slope, and saturation level, respectively, in control and VPA animals. (e) Representative traces of 10 evoked
inhibitory post-synaptic current (eIPSCs) in control (black) and VPA (grey) animals. (f ) Paired pulse ratio (PPR) A2/A1 in control
and VPA animals. (g) Coefficient of variation (1/CV2) analysis, averages for control (black) and VPA (grey). (h) Decay time in control
(black) and VPA (grey) animals. * p<0.05, ** p<0.02.
Zolpidem 1 0.6
–100 2 0
150 pA
50 ms
Zolpidem 1 2
0.5
Peak amplitude (pA)
50 ms
1 *
(Izolp –Ic)/Izolp(pA)
–200 –100
0.4
–300 –200 0.3
0.2
–400 –300 2
2
0.1
Con VPA
–500 –400 0.0
20 30 40 50 0 10 20 30 40 50 60 Con VPA
Time (min) Time (min)
(d) (e) (f )
Picrotoxin-sensitive Ih(pA/pF)
2.5
Picrotoxin 2.0 n.s.
Gaboxadol Picrotoxin
Gaboxadol
1.5
1.0
20 pA
20 pA
0.5
3 min
Con VPA 3 min
0.0
Con VPA
Fig. 3. Different modulation of synaptic and extra-synaptic GABAA receptors (GABAAR)-mediated currents : (a) Bath-application of
zolpidem (500 nm) showing a decrease of eIPSC amplitude in control animals. The insert shows an example of an evoked inhibitory
post-synaptic current (eIPSC) at an expanded scaling control (black) zolpidem (grey). The numbers 1 and 2 in the insert refer to the
average of four traces in the amplitude time-course. (b) Same as (a) but in valproic acid (VPA) animals ; time-course and traces (insert)
showing the effect of zolpidem (500 nm) in eIPSC ; control (black), zolpidem (grey). (c) Shows normalized zolpidem-induced change of
eIPSC amplitude in control and VPA animals (n=9). (d and e) Change in GABAAR-mediated tonic currents (in 10 mM 6,7-
dinitroquinoxaline-2,3-dione and 2 mM kynurenic acid). Examples of time-course of the bath-application of gaboxadol (5 mM), a specific
agonist for the extrasynaptic d subunit of GABAAR, which caused an increase of tonic conductance, revealed by increased holding
current blocked by picrotoxin (100 mM), in control and VPA animals, respectively. (f ) Mean of picrotoxin sensitive current in gaboxadol
normalized to the cell capacitance, control and VPA animals (n=11). * p<0.05.
150 pA
NE
2 *
50 ms *
–200 500 1.0
PPR
–400
250 0.5
1
–600
2
–800 0 0.0
0 10 20 30 40 Con NE Con NE
Time (min)
VPA
150 pA
1 1.5
2 100
50 ms
NE *
1.0 *
–50
PPR
50
–100 0.5
1 2
–150 0 0.0
30 40 50 60 70 80 90
Con NE Con NE
Time (min)
(e) (f )
(d) Con 300 1.5
2 *
eIPSC amplitude (pA)
0
150 pA
eIPSC amplitude (pA)
Oxo 1
1.2
–100 50 ms 500
*
PPR
0.8
–200 2
100
–300 0.4
1
–400 0 0.0
0 5 10 15 20 25 30
Time (min) Con Oxo Con Oxo
150
VPA 1.0
eIPSC amplitude (pA)
2
eIPSC amplitude (pA)
0.8
20 pA
Oxo 1 100
0
50 ms * 0.6
PPR
–50
50 0.4
–100 2 0.2
1
–150 0 0.0
0 10 20 30 40 50 60 Con Oxo Con Oxo
Time (min)
Fig. 4. Differential norepinephrine (NE) and oxotremorine (Oxo) on modulation of evoked inhibitory post-synaptic currents (eIPSCs) :
(a) Time-course and traces (in the inserts) showing the effect of bath application of NE (20 mM) on eIPSC amplitude in control and
valproic acid (VPA) animals, respectively (insert : baseline black ; NE grey). The numbers 1 and 2 in the insert refer to the average
of four traces in the amplitude time-course. (b) Average NE-induced change in eIPSC amplitude in control and VPA animals,
respectively. (c) Average NE-induced change in paired pulse ratio (PPR) in control and VPA animals, respectively (d) Time-course
and traces (in the inserts) showing the effect of bath application of Oxo (10 mM) on eIPSC amplitude in control and VPA animals,
respectively (insert : baseline, black, Oxo, grey). (e) Average Oxo-induced change in eIPSC amplitude in control and VPA animals,
respectively. (f) Average Oxo-induced change in PPR in control and VPA animals, respectively. * p<0.05.
As expected, bath application of norepinephrine at baseline vs. 1.01¡0.15 after NE, n=12 n.s., compared
(NE) increased the eIPSC amplitude from 405¡27 pA to 1.13¡0.03 at baseline vs. 0.86¡0.04 in NE in control
to 630.7¡41 pA in control animals, corresponding to animals ; Fig. 4c).
68.5¡7.1 % (see example of eIPSC amplitude time-course We also compared the effects of the muscarinic agonist
in Fig. 4 a). On the contrary, NE failed to show a similar oxotremorine on eIPSC amplitude and PPR. We found
increase in eIPSC modulation in VPA animals from that oxotremorine decreased eIPSC amplitude both in
85.5¡15.25 pA to 103.23¡10.8 pA after NE, correspond- control (from 275¡10 pA to 102¡9 pA, n=12, p<0.02 ;
ing to 25¡6 % increase (n=12, p<0.05 ; Fig. 4 a). The example of eIPSC amplitude time-course in Fig. 4d) and
mean eIPSC amplitudes are shown for control and VPA VPA animals (from 110.8¡15.1 pA to 78.9¡11.21 pA,
animals in Fig. 4 b (n=12, p<0.05 % ; n=11, n.s.). Also, n=9, p>0.05 ; example of eIPSC amplitude time-course
while in control animals NE significantly decreased PPR, in Fig. 4 d). However, the extent of the oxotremorine-
NE failed to affect PPR in VPA animals (PPR=1.08¡0.17 induced decrease in eIPSC amplitude significantly
differed between control and VPA animals (68¡5 % in of benzodiazepine binding sites (Oblak et al. 2009, 2011)
control animals vs. 28¡5 % in VPA animals, p<0.05). and GABAAR (Fatemi et al. 2009 ; Fukuchi et al. 2009) in
Mean eIPSC amplitudes are shown in Fig. 4 e for control autoptic brains from ASD sufferers.
and VPA animals, respectively. PPR changed significantly Also, in line with our results is the observation that
in control rats (1.0¡0.07 in baseline vs. 1.43¡0.10 in some subtypes of ASDs are linked to anomalies in
oxotremorine, n=17, p<0.05 % ; Fig. 4 f) whereas it did chromosomal region 15q11-q13, which possesses a gene
not change in VPA animals (PPR=0.63¡0.09 in baseline cluster encoding for multiple subunits of the GABAAR
vs. 0.72¡0.07 in oxotremorine, n=12, n.s.). Altogether, (Shao et al. 2003). Interestingly, deletion of the gene
these data suggest that pre-synaptic regulation of encoding for the b3 subunit of the GABAAR in mouse
GABAergic terminals is quantitatively and qualitatively displays epilepsy, as well as symptoms resembling
altered in VPA animals. Angelman syndrome, another disorder of the autistic
spectrum (Homanics et al. 1997 ; DeLorey et al. 1998,
2008).
Discussion
Our results show for the first time that GABAergic Deficit in pre-synaptic modulation
transmission is severely compromised in VPA animals. The presence of post-synaptic alterations does not
While the decreased frequency of mIPSCs qualitatively exclude the possibility of concomitant pre-synaptic
resembles the data found in the Rett syndrome model changes. GABAergic axons in autoptic brains from ASD
(Zhang et al. 2008), suggestive of a pre-synaptic deficit, patients display marked decrease in the levels of gluta-
the slower kinetic, typical of immature neurons (Cohen mate decarboxylase (Fatemi et al. 2002 ; Yip et al. 2007,
et al. 2000) indicated a post-synaptic alteration. 2009 ; Buttenschon et al. 2009), suggesting an impairment
of interneuronal pre-synaptic function. In our experi-
Post-synaptic impairment of GABAergic transmission ments, the decreased mIPSC frequency, the failure of
in VPA synapses GABAergic axons to display sensitivity to NE (>60 %
increase in controls but only y10 % in VPA) and the
The remarkable decrease in slope and saturation level
milder deficit in muscarinic modulation (y67 % in con-
(down to only y20 % of control) in I/O curves and the
trols but only y27 % in VPA), might be among multiple
absence of significant changes in PPR or CV further sup-
impairments in local interneuronal pre-synaptic function.
ported a dramatic impairment of post-synaptic function
Alterations in cortical interneuronal circuitry might be
in VPA animals. The reduced sensitivity of VPA animals
caused by failure of proper differentiation, migration
to zolpidem, which enhances GABAergic currents by pre-
and/or proliferation of GABAergic neurons (Schmitz
ferentially binding to intra-synaptic GABAAR a subunits,
et al. 2005), which control the balance between synaptic
suggested that VPA inhibitory synapses might have a
excitation and inhibition (Freund, 2003). Further support
different subunit composition compared to controls, in
to the hypothesis of an impaired inhibitory system in ASD
agreement also with the different kinetics of mIPSCs.
comes from changes in the distribution of GABAergic
A different sensitivity to zolpidem of GABAAR-mediated
neurons in autoptic tissue from autistic patients
currents was also found in oocytes injected with
(Lawrence et al. 2010) and fragile X syndrome patients
GABAARs from Angelman patients (Roden et al. 2010).
(Selby et al. 2007), paralleled by altered expression and
The low sensitivity of VPA inhibitory synapses to zolpi-
density of GABAergic markers in other brain areas in
dem could be due to the insertion in the membrane of
VPA (Dendrinos et al. 2011) and other animal models
GABAARs from extra-synaptic or even intra-cellular ori-
of ASD (Gogolla et al. 2009), detected for parvalbumin-,
gin. Different from synaptic GABAergic currents, we
calbindin- and calretinin-positive interneurons (Lawrence
found no changes in the extent of tonic GABAergic cur-
et al. 2010). The slower mIPSC kinetics might be due to a
rents, measured as the picrotoxin-sensitive component of
selective decrease in number or effectiveness of somatic
the holding current after application of THIP, a specific
inhibitory synapses between interneurons and pyramidal
allosteric agonist of extra-synaptic GABAARs (Drasbek
cells, possibly caused by an early dysfunction in chemo-
and Jensen, 2006). A different response to zolpidem,
attractive/repulsive mechanisms regulating the proper
but not to THIP, could be due to an abnormal delivery of
development of immature GABAergic cells (Flames et al.
synaptic-specific subunits of GABAARs to GABAergic
2004 ; Hernandez-Miranda et al. 2010).
synapses in VPA animals, consistent with a failure of
normal endosome-membrane trafficking of GABAAR
Functional consequences of the GABAergic deficit
subunits postulated in ASD (Momoi et al. 2010). These
data are also consistent with one of the earliest reports of Numerous earlier studies have reported an enhanced
a decrease in GABAAR density, in contrast to a normal excitatory transmission and long-term plasticity in VPA
distribution of glutamatergic, serotoninergic and choli- animals (Rinaldi et al. 2007 ; Silva et al. 2009). These and
nergic receptors, obtained using neurochemical techni- other work suggested the ‘intense world theory ’ of ASD
ques (Blatt et al. 2001), as well as with a decreased density (Markram et al. 2007 ; Markram and Markram, 2010),
in which an abnormally elevated cortical local excitability enhancement of locally-controlled tasks but impaired
would give rise to emotional and sensory hypersen- higher-level processing. A corollary of this hypothesis
sitivity characteristic of ASD patients. An impaired is that treatment with allosteric modulators of synaptic
GABAergic system would produce an additional shift in GABAARs, or other drugs restoring the excitation :
the excitatory :inhibitory ratio, further contributing to inhibition ratio to physiological levels might override the
local hyperexcitability. Altogether, these data converge to deleterious effects of the synaptic unbalance, as long as
support the hypothesis that in spite of the heterogeneity treatment occurs before the stabilization of the glutama-
in the range of genetic, epigenetic and environmental tergic circuits for communication and social interactions.
factors at the root of ASD, an increased ratio between
cortical synaptic excitation and inhibition might be a
Supplementary material
shared mechanism in ASD (Rubenstein and Merzenich,
2003 ; Yizhar et al. 2011). This hypothesis is hardly new in For supplementary material accompanying this paper
the interpretation of neurological and psychiatric condi- visit http://dx.doi.org/10.1017/S1461145712001216.
tions, since an increased excitation :inhibition ratio has
also been hypothesized to be a critical factor in the aeti- Acknowledgements
ology of anxiety (Mohler, 2006), schizophrenic psychoses
(Kehrer et al. 2008), epilepsy (Fritschy, 2008 ; Trevino et al. We thank Dr Crystal Engineer for advice during the
2011), insomnia (Mohler, 2006), depression (Sanacora execution of the project and for critical review of the
et al. 2004) and catatonia (Daniels, 2009). The differences manuscript. This work was funded with Research
in the clinical manifestation of these disorders might Development funds from the School of Behavioural and
originate in the timing (prenatal, early post-natal, or Brain Sciences to M.A. and with the National Institutes of
adult) and duration (acute vs. prolonged) of the biological Health R01DC010433 grant to M.P.K.
insult, as well as in genetic predisposition. The pervasive
nature of ASD symptoms might be rooted in an early Statement of Interest
peri-natal hyperexcitability at a critical time for storing
and solidification of the complex set of social and com- None.
munication rules implemented by the developing neo-
cortex. In contrast, a recent optogenetics study (Yizhar References
et al. 2011) suggests that an imbalance between inhibition
Antshel KM, Polacek C, McMahon M, Dygert K, Spenceley L,
and excitation in favour of the latter can acutely impair
Dygert L, Miller L, Faisal F (2011) Comorbid ADHD and
social behaviour, independent of long-term circuit
anxiety affect social skills group intervention treatment
changes. Regardless of whether long- or short-term efficacy in children with autism spectrum disorders.
changes are necessary to produce autistic symptoms, our J Dev Behav Pediatr 32 :439–446.
data corroborate the hypothesis that the increase in syn- Atzori M, Lei S, Evans DI, Kanold PO, Phillips-Tansey E,
aptic excitatory :inhibitory balance is a hallmark of ASD. McIntyre O, McBain CJ (2001) Differential synaptic processing
A lack of behavioural flexibility often observed in ASD separates stationary from transient inputs to the auditory
patients might be, at least in part, secondary to a deficient cortex. Nat Neurosci 4 :1230–1237.
control of GABAergic transmission by the modulatory Bassell GJ, Warren ST (2008) Fragile X syndrome : loss of local
systems, including the noradrenergic and the cholinergic mRNA regulation alters synaptic development and function.
Neuron 60 :201–214.
systems (Salgado et al. 2007, 2011). The improvement
Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL,
in impulsivity, inattention, hyperactivity and aggress-
Bauman ML (2001) Density and distribution of hippocampal
iveness symptoms, following administration of the a2 neurotransmitter receptors in autism : an autoradiographic
adrenergic agonist clonidine in a cohort of ASD children study. J Autism Dev Disord 31 :537–543.
(Ming et al. 2008) would support this interpretation. The Bourgeron T (2007) The possible interplay of synaptic and clock
integrity of the GABAergic interneuronal network is es- genes in autism spectrum disorders. Cold Spring Harb Symp
sential in the generation of c-oscillations, coordinating Quant Biol 72 :645–654.
local with distant neuronal processing. Buttenschon HN, Lauritsen MB, El Daoud A, Hollegaard M,
A deficit in GABAergic transmission implemented Jorgensen M, Tvedegaard K, Hougaard D, Borglum A,
by local interneuronal network might then explain Thorsen P, Mors O (2009) A population-based association
study of glutamate decarboxylase 1 as a candidate gene for
the abnormal c-rhythms monitored in autistic subjects
autism. J Neural Transm 116 :381–388.
(Orekhova et al. 2007). It has been recently proposed
Calfa G, Percy AK, Pozzo-Miller L (2011) Experimental models
that the failure to synchronize biological and circadian
of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med
rhythms in new-borns might be a causal factor for ASD (Maywood) 236 :3–19.
(Bourgeron, 2007). Consistent with this hypothesis we Cohen AS, Lin DD, Coulter DA (2000) Protracted postnatal
speculate that an early impairment of the GABAergic development of inhibitory synaptic transmission in rat
system might alter the extent and functional properties hippocampal area CA1 neurons. J Neurophysiol
of local cortical excitatory circuits leading in turn to an 84 :2465–2476.
Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth
Lancet 372 :657–668. A, Harrison NL, Krasowski MD, Rick CE, Korpi ER, Makela R,
Daniels J (2009) Catatonia : clinical aspects and neurobiological Brilliant MH, Hagiwara N, Ferguson C, Snyder K, Olsen RW
correlates. J Neuropsychiatry Clin Neurosci 21 :371–380. (1997) Mice devoid of gamma-aminobutyrate type A receptor
DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, beta3 subunit have epilepsy, cleft palate and hypersensitive
Minassian BA, Asatourian A, Fanselow MS, Delgado-Escueta behavior. Proc Natl Acad Sci USA 94 :4143–4148.
A, Ellison GD, Olsen RW (1998) Mice lacking the beta3 subunit Hussman JP (2001) Suppressed GABAergic inhibition as a
of the GABAA receptor have the epilepsy phenotype and common factor in suspected etiologies of autism. J Autism
many of the behavioral characteristics of Angelman Dev Disord 31 :247–248.
syndrome. J Neurosci 18 :8505–8514. Jacob TC, Moss SJ, Jurd R (2008) GABA(A) receptor trafficking
DeLorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD and its role in the dynamic modulation of neuronal inhibition.
(2008) Gabrb3 gene deficient mice exhibit impaired social Nat Rev Neurosci 9 :331–343.
and exploratory behaviors, deficits in non-selective attention Kehrer C, Maziashvili N, Dugladze T, Gloveli T (2008) Altered
and hypoplasia of cerebellar vermal lobules : a potential excitatory-inhibitory balance in the NMDA-hypofunction
model of autism spectrum disorder. Behav Brain Res model of schizophrenia. Front Mol Neurosci 1 :6.
187 :207–220. Kim J, Alger BE (2001) Random response fluctuations lead to
Dendrinos G, Hemelt M, Keller A (2011) Prenatal VPA exposure spurious paired-pulse facilitation. J Neurosci 21 :9608–9618.
and changes in sensory processing by the superior colliculus. Lawrence YA, Kemper TL, Bauman ML, Blatt GJ (2010)
Front Integr Neurosci 5 :68. Parvalbumin-, calbindin-, and calretinin-immunoreactive
Drasbek KR, Jensen K (2006) THIP, a hypnotic and hippocampal interneuron density in autism. Acta Neurol
antinociceptive drug, enhances an extrasynaptic GABAA Scand 121 :99–108.
receptor-mediated conductance in mouse neocortex. Cereb Markram K, Markram H (2010) The intense world theory – a
Cortex 16 :1134–1141. unifying theory of the neurobiology of autism. Front Hum
Faber DS, Korn H (1991) Applicability of the coefficient of Neurosci 4 :224.
variation method for analyzing synaptic plasticity. Biophys J Markram H, Rinaldi T, Markram K (2007) The intense world
60 :1288–1294. syndrome – an alternative hypothesis for autism. Front
Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto Neurosci 1 :77–96.
GR (2002) Glutamic acid decarboxylase 65 and 67 kDa Ming X, Gordon E, Kang N, Wagner GC (2008) Use of clonidine
proteins are reduced in autistic parietal and cerebellar in children with autism spectrum disorders. Brain Dev
cortices. Biol Psychiatry 52 :805–810. 30 :454–460.
Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009) GABA(A) Mohler H (2006) GABAA receptors in central nervous system
receptor downregulation in brains of subjects with autism. J disease : anxiety, epilepsy, and insomnia. J Recept Signal
Autism Dev Disord 39 :223–230. Transduct Res 26 :731–740.
Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Momoi T, Fujita E, Senoo H, Momoi M (2010) Genetic factors and
Birchmeier C, Lai C, Rubenstein JL, Marin O (2004) Short- and epigenetic factors for autism : endoplasmic reticulum stress
long-range attraction of cortical GABAergic interneurons by and impaired synaptic function. Cell Biol Int 34 :13–19.
neuregulin-1. Neuron 44 :251–261. Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ,
Freund TF (2003) Interneuron diversity series : rhythm and mood Montgomery T, Dean JC (2000) A clinical study of 57 children
in perisomatic inhibition. Trends Neurosci 26 :489–495. with fetal anticonvulsant syndromes. J Med Genet 37 :489–497.
Fritschy JM (2008) Epilepsy, E/I balance and GABA(A) receptor Oblak A, Gibbs TT, Blatt GJ (2009) Decreased GABAA receptors
plasticity. Front Mol Neurosci 1 :5. and benzodiazepine binding sites in the anterior cingulate
Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, cortex in autism. Autism Res 2 :205–219.
Tabuchi A, Tsuda M (2009) Valproic acid induces up- or Oblak AL, Gibbs TT, Blatt GJ (2011) Reduced GABAA receptors
down-regulation of gene expression responsible for the and benzodiazepine binding sites in the posterior cingulate
neuronal excitation and inhibition in rat cortical neurons cortex and fusiform gyrus in autism. Brain Res 1380 :218–228.
through its epigenetic actions. Neurosci Res 65 :35–43. Orekhova EV, Stroganova TA, Nygren G, Tsetlin MM, Posikera
Glickman G (2010) Circadian rhythms and sleep in children with IN, Gillberg C, Elam M (2007) Excess of high frequency
autism. Neurosci Biobehav Rev 34 :755–768. electroencephalogram oscillations in boys with autism. Biol
Gogolla N, Leblanc JJ, Quast KB, Sudhof T, Fagiolini M, Psychiatry 62 :1022–1029.
Hensch TK (2009) Common circuit defect of excitatory- Parikh MS, Kolevzon A, Hollander E (2008)
inhibitory balance in mouse models of autism. J Neurodev Psychopharmacology of aggression in children and
Disord 1 :172–181. adolescents with autism : a critical review of efficacy and
Goldman SE, Surdyka K, Cuevas R, Adkins K, Wang L, Malow tolerability. J Child Adolesc Psychopharmacol 18 :157–178.
BA (2009) Defining the sleep phenotype in children with Pizzarelli R, Cherubini E (2011) Alterations of GABAergic
autism. Dev Neuropsychol 34 :560–573. signaling in autism spectrum disorders. Neural Plast
Hazlett HC, Poe MD, Gerig G, Styner M, Chappell C, Smith RG, 2011 :297153.
Vachet C, Piven J (2011) Early brain overgrowth in autism Rasalam AD, Hailey H, Williams JH, Moore SJ, Turnpenny PD,
associated with an increase in cortical surface area before age Lloyd DJ, Dean JC (2005) Characteristics of fetal
2 years. Arch Gen Psychiatry 68 :467–476. anticonvulsant syndrome associated autistic disorder.
Hernandez-Miranda LR, Parnavelas JG, Chiara F (2010) Dev Med Child Neurol 47 :551–555.
Molecules and mechanisms involved in the generation and Rinaldi T, Kulangara K, Antoniello K, Markram H (2007)
migration of cortical interneurons. ASN Neuro 2 :e00031. Elevated NMDA receptor levels and enhanced postsynaptic
long-term potentiation induced by prenatal exposure to to chromosome 15q11-q13 by use of phenotypic subtypes.
valproic acid. Proc Natl Acad Sci USA 104 :13501–13506. Am J Hum Genet 72 :539–548.
Rinaldi T, Perrodin C, Markram H (2008a) Hyper-connectivity Silva GT, Le Be JV, Riachi I, Rinaldi T, Markram K, Markram H
and hyper-plasticity in the medial prefrontal cortex in the (2009) Enhanced long-term microcircuit plasticity in the
valproic acid animal model of autism. Front Neural Circuits valproic acid animal model of autism. Front Synaptic
2 :4. Neurosci 1 :1.
Rinaldi T, Silberberg G, Markram H (2008b) Hyperconnectivity Souders MC, Mason TB, Valladares O, Bucan M, Levy SE,
of local neocortical microcircuitry induced by prenatal Mandell DS, Weaver TE, Pinto-Martin J (2009) Sleep behaviors
exposure to valproic acid. Cereb Cortex 18 :763–770. and sleep quality in children with autism spectrum disorders.
Roden WH, Peugh LD, Jansen LA (2010) Altered GABA(A) Sleep 32 :1566–1578.
receptor subunit expression and pharmacology in human Spiker MA, Lin CE, Van Dyke M, Wood JJ (2012) Restricted
Angelman syndrome cortex. Neurosci Lett 483 :167–172. interests and anxiety in children with autism. Autism
Rubenstein JL, Merzenich MM (2003) Model of autism : increased 16 :306–320.
ratio of excitation/inhibition in key neural systems. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M,
Genes Brain Behav 2 :255–267. Futatsubashi M, Iwata Y, Tsuchiya KJ, Matsumoto K,
Rutkowski RG, Miasnikov AA, Weinberger NM (2003) Takebayashi K, Wakuda T, Yoshihara Y, Suda S, Kikuchi M,
Characterisation of multiple physiological fields within the Takei N, Sugiyama T, Irie T, Mori N (2011) Reduced
anatomical core of rat auditory cortex. Hear Res 181 :116–130. acetylcholinesterase activity in the fusiform gyrus in adults
Salgado H, Bellay T, Nichols JA, Bose M, Martinolich L, with autism spectrum disorders. Arch Gen Psychiatry
Perrotti L, Atzori M (2007) Muscarinic M2 and M1 receptors 68 :306–313.
reduce GABA release by Ca2+ channel modulation through Thatcher RW, North DM, Neubrander J, Biver CJ, Cutler S,
activation of PI3K/Ca2+-independent and PLC/Ca2+- Defina P (2009) Autism and EEG phase reset : deficient GABA
dependent PKC. J Neurophysiol 98 :952–965. mediated inhibition in thalamo-cortical circuits. Dev
Salgado H, Garcia-Oscos F, Dinh L, Atzori M (2011) Dynamic Neuropsychol 34 :780–800.
modulation of short-term synaptic plasticity in the auditory Trevino M, Vivar C, Gutierrez R (2011) Excitation-inhibition
cortex : the role of norepinephrine. Hear Res 271 :26–36. balance in the CA3 network – neuronal specificity and
Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, activity-dependent plasticity. Eur J Neurosci 33 :1771–1785.
Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific Tuchman R, Cuccaro M (2011) Epilepsy and autism :
alterations of gamma-aminobutyric acid and glutamate in neurodevelopmental perspective. Curr Neurol Neurosci Rep
patients with major depression. Arch Gen Psychiatry 11 :428–434.
61 :705–713. Tuchman R, Cuccaro M, Alessandri M (2010) Autism and
Schmitz C, van Kooten IA, Hof PR, van Engeland H, epilepsy : historical perspective. Brain Dev 32 :709–718.
Patterson PH, Steinbusch HW (2005) Autism : Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH
neuropathology, alterations of the GABAergic system, and (2001) Fetal valproate syndrome and autism : additional
animal models. Int Rev Neurobiol 71 :1–26. evidence of an association. Dev Med Child Neurol 43 :202–206.
Schneider T, Przewlocki R (2005) Behavioral alterations in rats Yip J, Soghomonian JJ, Blatt GJ (2007) Decreased GAD67 mRNA
prenatally exposed to valproic acid : animal model of autism. levels in cerebellar Purkinje cells in autism :
Neuropsychopharmacology 30 :80–89. pathophysiological implications. Acta Neuropathol
Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska 113 :559–568.
B, Schneider K, Przewlocki R (2008) Gender-specific Yip J, Soghomonian JJ, Blatt GJ (2009) Decreased GAD65 mRNA
behavioral and immunological alterations in an animal model levels in select subpopulations of neurons in the cerebellar
of autism induced by prenatal exposure to valproic acid. dentate nuclei in autism : an in situ hybridization study.
Psychoneuroendocrinology 33 :728–740. Autism Res 2 :50–59.
Schneider T, Ziolkowska B, Gieryk A, Tyminska A, Przewlocki R Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ,
(2007) Prenatal exposure to valproic acid disturbs the O’Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K,
enkephalinergic system functioning, basal hedonic tone, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P,
and emotional responses in an animal model of autism. Deisseroth K (2011) Neocortical excitation/inhibition balance
Psychopharmacology (Berl) 193 :547–555. in information processing and social dysfunction. Nature
Selby L, Zhang C, Sun QQ (2007) Major defects in neocortical 477 :171–178.
GABAergic inhibitory circuits in mice lacking the fragile X Zhang L, He J, Jugloff DG, Eubanks JH (2008) The MeCP2-null
mental retardation protein. Neurosci Lett 412 :227–232. mouse hippocampus displays altered basal inhibitory
Shao Y, Cuccaro ML, Hauser ER, Raiford KL, Menold MM, rhythms and is prone to hyperexcitability. Hippocampus
Wolpert CM, Ravan SA, Elston L, Decena K, Donnelly SL, 18 :294–309.
Abramson RK, Wright HH, DeLong GR, Gilbert JR, Zucker RS, Regehr WG (2002) Short-term synaptic plasticity.
Pericak-Vance MA (2003) Fine mapping of autistic disorder Annu Rev Physiol 64 :355–405.